The Cochrane Tobacco Addiction Group (CTAG) has been responsible for excellent research but has now lost all funding from the National Institute for Health Research (NIHR).
The funding for its work will run out in 2023, and CTAG has consulted on the best way to approach the future.
CTAG released a statement saying: “In August 2021, our principal funder, the National Institute for Health Research (NIHR) informed us that they will terminate all funding to Cochrane Review Groups as of March 2023. We are grateful to have benefitted from many years of stable funding from the NIHR.
“In response to this situation, Cochrane has decided to disband the Cochrane Review Groups and move to a new review production model. Cochrane is in the process of developing this new model, and you can join in that discussion here.
“We are not certain what the future holds, but we do know that CTAG will cease to exist at the end of March 2023. We would like to take this opportunity to thank everyone who has contributed to Cochrane Tobacco Addiction over the last 25 years.
Dave Cross – Planet of the Vapes – 2021-11-29.
Want More Investigative Content?
